for Veterans and the Public

In patients who complete drug therapy, the virus is cleared from the blood (an SVR) about 45% of the time if the patient is genotype 1 and about 65%-75% of the time if the patient is genotype 2 or 3.

Other factors can change how likely it is that treatment is successful.

Being HIV-HCV coinfected lowers the chance of treatment success. Having more advanced fibrosis or cirrhosis lowers the chance of treatment success. Having a low viral load prior to treatment increases the chance of treatment success. These are a few of many potential factors which can make it more or less likely that treatment will result in an SVR.